Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

Comparative Hepatology

Open Access

Elevated levels of tissue inhibitor of metalloproteinases (TIMPS) in human hepatocellular carcinomas

  • Eiji Matsumoto1Email author,
  • Harushige Nakatsukasa1,
  • Kazuhiro Nouso1,
  • Shin-ichiro Nakamura1,
  • Mayumi Suzuki1,
  • Yoshiyuki Kobayashi1,
  • Masayuki Uemura1,
  • Syuichiro Sato1,
  • Ei-ichiro Yumoto1,
  • Junko Yokoyama1,
  • Sou Tsuboi1,
  • Hironori Tanaka1,
  • Yoshiataka Takuma1,
  • Tatsuya Fujikawa1 and
  • Yasushi Shiratori1
Comparative Hepatology20043(Suppl 1):S51

https://doi.org/10.1186/1476-5926-2-S1-S51

Published: 14 January 2004

Introduction

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in Japan. Invasion and metastasis of HCC are frequently observed during the development of HCCs, and are regulated by matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). We have previously reported the strong expression of TIMP-1 and TIMP-2, and cellular localization of the transcripts in HCCs [1]. But the mechanisms of invasion and metastasis of HCCs, and particularly the role of TIMPs are still unclear. The purpose of this study was to examine the tissue concentration of the TIMP-1 and to study the potential involvement of TIMP-1 in the development of HCCs.

Methods

Patients and Tissue Preparation

A total of 60 HCC nodules that received curative surgical resection were studied. The nodules had received no pretreatment. Clinical backgrounds of the patients are shown in Table 1. The tissue was divided into HCC and non-neoplastic liver. Tissue samples (~100 mg) of HCC and non-neoplastic liver were homogenized in 150 microliters of 0.5 M Tris, 1.5 M NaCl, 50 mM CaCl2, 2 mM sodium azide, pH 7.6. The homogenate was centrifuged at 15000 – g for 15 min at 4 degrees C and the supernatant was stored at -80 degrees C until analysis.
Table 1

Characteristics of the Patients Investigated in this Study

  

n

Cases

 

58

HCC nodules

60

 

Age

46–75 (median 66)

 

Sex

Male

46

 

Female

12

Background

Chronic hepatitis

42

 

Liver cirrhosis

16

Viral infection

hepatitis B virus (HBV)

14

 

hepatitis C virus (HCV)

42

 

HBV and HCV

2

Serum AFP (ng/ml, mean – SD)

766 – 2935

 

Tumor size in diameter (mm, mean – SD)

31 – 21

 

Assay for tissue TIMP-1 concentration

TIMP-1 concentration in the supernatant of tissue homogenate of HCC and non-neoplastic liver was measured by a Enzyme-Linked Immunosorbent Assay system, using a commercial assay kit (Fuji Chemical Co. Japan), which contains two kinds of monoclonal antibodies against bovine TIMP-1.

Statistics

Difference between the tissue TIMP-1 concentration of HCC and that of non-neoplastic liver was examined by Student's t test. The Mann-Whitney's U-test was performed to compare the relationship between tissue TIMP-1 concentration and clinicopathological features.

Results

Tissue TIMP-1 concentration

The TIMP-1 concentration in HCC was 520 – 602 (mean – SD) ng/mg protein, and was significantly (p < 0.0001) higher than that in the corresponding non-neoplastic liver (114 – 212).

Correlation between tissue TIMP-1 concentration and pathological features

The TIMP-1 concentration in HCC was examined in the various conditions of HCC invasion; those include the differentiation grade, the presence or absence of capsular formation, the capsular invasion, and the vascular invasion. These results are shown in Table 2. The TIMP-1 concentration of HCC in poorly differentiated HCC was higher than that in well and moderately differentiated HCC (p < 0.01 and p < 0.02, respectively).
Table 2

TIMP-1 concentration and pathological features of HCCs

   

TIMP-1 concentration in

 

Category

n

HCC

NN

Differentiation grade

Well

12

177*

55

 

Moderate

42

254**

63

 

Poor

6

1020***

74

Capsular formation

present

48

228

63

 

absent

12

564

51

Capsular invasion

present

39

244

72

 

absent

9

211

45

Vascular invasion

present

13

867

63

 

absent

47

252

57

* vs ***: p < 0.01 ** vs ***: p < 0.02 TIMP-1 concentrations are expressed as median value. NN: non-neoplastic liver.

Correlation between tissue TIMP-1 concentration and clinical features

The TIMP-1 concentration in HCC was examined in the various conditions of clinical features, that include the age of the patients, the underlying liver (liver cirrhosis or chronic hepatitis), the type of viral infection (hepatitis B virus or hepatitis C virus), serum alpha fetoprotein (AFP) levels, and tumor size. The TIMP-1 concentration in liver cirrhosis was higher than that in chronic hepatitis (p < 0.01).

Discussion

The present study demonstrated that tissue TIMP-1 concentration in HCCs was significantly higher than that in non-neoplastic liver and that the TIMP-1 concentration in poorly differentiated HCCs was significantly higher than that of well and moderately differentiated HCCs. We have previously reported by using in situ hybridization that the expression of TIMP-1 in HCCs was stronger than that in non-neoplastic liver [1]. The present study further confirms that TIMP-1 is up-regulated in HCCs not only in the transcription but also in the translation level. The primary biological function of TIMPs is the inhibition of MMPs. When the cancer invades the surrounding non-neoplastic tissue, MMPs may play a major role to degrade extracellular matrices. TIMPs play an important role in the regulation of the action of MMPs. But, it has been reported that tissue TIMP-1 concentration in gastric cancer was associated with various pathological factors, and patients with high tissue TIMP-1 concentration had poor prognosis in comparison to those with low TIMP-1 level [2]. The elevated TIMP-1 level was also associated with poor prognosis in lung cancer [3]. It is intriguing that the TIMP-1 concentration in poorly differentiated HCCs was significantly higher than that of well and moderately differentiated HCCs. Our previous studies on mRNA level have not shown the similar results to the present study on the protein level. Generally, the lower the differentiation grade of HCCs, the stronger potential of growth, invasion and metastasis. TIMP-1 has been reported to be a new cell-growth factor [4] and also an anti-angiogenic factor [5]. These lines of evidence may be associated with the reason why the TIMP-1 concentration in poorly differentiated HCCs was high. Further studies on the functional role of TIMPs in HCCs are needed.

Authors’ Affiliations

(1)
Department of Medicine and Medical Science, Okayama University Graduate School of Medicine and Dentistry, and Seno Hospital of Okayama City

References

  1. Nakatsukasa H, Ashida K, Higashi T, Ohguchi S, Tsuboi S, Hino N, Nouso K, Urabe Y, Kinugasa N, Yoshida K, et al: Cellular distribution of transcripts for tissue inhibitor of metalloproteinases-1 and -2 in human hepatocellular carcinomas. Hepatology. 1996, 24: 82-88. 10.1002/hep.510240115.View ArticlePubMedGoogle Scholar
  2. Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y: Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomarker for invasion and its impact on survival. Cancer. 2001, 91: 1739-1744. 10.1002/1097-0142(20010501)91:9<1739::AID-CNCR1192>3.0.CO;2-9.View ArticlePubMedGoogle Scholar
  3. Ylisirnio S, Hoyhtya M, Makitaro R, Paaakko P, Risteli J, Kinnula V, Turpeenniemi-Hujanen T, Jukkola A: Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res. 2001, 7: 1633-1637.PubMedGoogle Scholar
  4. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 1992, 298: 29-32. 10.1016/0014-5793(92)80015-9.View ArticlePubMedGoogle Scholar
  5. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL: Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol. 1993, 156: 235-246. 10.1002/jcp.1041560204.View ArticlePubMedGoogle Scholar

Copyright

© Matsumoto et al; licensee BioMed Central Ltd 2004

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement